A Cry for Help? FDA Bares Concerns in NEJM

Orthopedics This Week by RRY Publications, LLC

May 11, 201714:08Science & Medicine

The most senior FDA executives went public with their worries, frustration even, we suspect, impotence regarding the plethora of stem cells therapies in the market last November. And that article, which appeared in the N...

Related Episodes

Continue listening to more episodes from Orthopedics This Week.

New Bill Streamlines Medical Device Process

Jul 5, 2017 - 09:50

Bipartisan bill HR 2474 the Medical Product Review Harmonization Act of 2017 was submitted by California...

Hanging Tough: Lumbar Disc Replacement Over Fusion

Jul 5, 2017 - 06:50

Jack Zigler keeps tracking his ProDisc patients, now 12 years post FDA approval. Just as he found at 3 ye...

Spooks, Phishing and Cyberattacks Cripple Hospitals

May 30, 2017 - 11:10

Spook technology stolen from U.S. spy agencies was used by hackers in a phishing cyberattack that cripple...

Systemic Bias in Clinical Research

May 30, 2017 - 13:12

Orthopedics This Week calls for a change in the economic framework for the clinical study process globall...

The Last Men Standing

May 26, 2017 - 10:16

Once upon a time lumbar arthroplasty was the most innovative and exciting development in spine surgery. T...

HCAHPS Report Card: A+ or C-?

May 11, 2017 - 10:09

Millions of patients have evaluated their hospital, physician and nurse experience by way of the HCAHPS s...

All Aboard the Opioid Tax BOAT

May 11, 2017 - 07:18

A bill is pending to amend the Internal Revenue Code's Public Health Service Act (PHSA). The Budgeting fo...

New MIS Spine Study Group Launch; New Study Targets Cellular RA Triggers; Active Implants Names Ted Davis President, CEO

Apr 13, 2017 - 07:39

Kern Singh, M.D. is advancing the science of spine with the establishment of the MISSG. New research sugg...